Back
Redhill Biopharma Vs. Can Fite Biofarma Industry Stock Comparison
Sell
22
RDHL
Redhill Biopharma
Last Price:
0.47
Seasonality Move:
-4.53%
Buy
54
CANF
Can Fite Biofarma
Last Price:
2.47
Seasonality Move:
-8.35%
Sell
22
Redhill Biopharma (RDHL)
is a Sell
Is Redhill Biopharma a Buy, Sell or Hold?
- The current Redhill Biopharma [RDHL] share price is $0.47. The Score for RDHL is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- RDHL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Can Fite Biofarma (CANF)
is a Buy
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $2.38. The Score for CANF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- CANF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RDHL Stock Price Chart
What is Redhill Biopharma's stock price today?
-
The Redhill Biopharma share price today is $0.47
The current trend is relatively stagnant and RDHL is experiencing selling pressure, which indicates risk of future bearish movement.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $2.38
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CANF is experiencing buying pressure, which is a positive indicator for future bullish movement.
RDHL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 54.2 | Buy |
| Chaikin Money Flow: | -295194 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.42 - 0.46) | Buy |
| Bollinger Bands (100): | (0.35 - 0.95) | Sell |
CANF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 65.31 | Buy |
| Chaikin Money Flow: | 30742 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.96 - 2.16) | Buy |
| Bollinger Bands (100): | (1.99 - 2.21) | Buy |
RDHL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.46 | Buy |
| 20-day SMA: | 0.45 | Buy |
| 50-day SMA: | 0.48 | Sell |
| 200-day SMA: | 0.73 | Sell |
| 8-day EMA: | 0.46 | Buy |
| 20-day EMA: | 0.46 | Buy |
| 50-day EMA: | 0.5 | Sell |
| 200-day EMA: | 2.41 | Sell |
CANF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.15 | Buy |
| 20-day SMA: | 2.07 | Buy |
| 50-day SMA: | 2.15 | Buy |
| 200-day SMA: | 2.24 | Buy |
| 8-day EMA: | 2.18 | Buy |
| 20-day EMA: | 2.12 | Buy |
| 50-day EMA: | 2.12 | Buy |
| 200-day EMA: | 2.46 | Sell |
Redhill Biopharma Earnings Growth & RDHL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
Redhill Biopharma Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Can Fite Biofarma Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||